Education, Science, Technology, Innovation and Life
Open Access
Sign In

Hypertensive Disorders of Pregnancy: Causes, Diagnosis, Complications, and Management Strategies

Download as PDF

DOI: 10.23977/medsc.2024.050111 | Downloads: 6 | Views: 134

Author(s)

Caixia Liu 1, Xiaoli Liu 1

Affiliation(s)

1 Shenshan Medical Center, Memorial Hospital of Sun Yat-Sen University, Shanwei, China

Corresponding Author

Caixia Liu

ABSTRACT

Pregnancy-induced hypertension refers to elevated blood pressure occurring in pregnant women after the 20th week of gestation, with the potential to progress into severe conditions such as preeclampsia and eclampsia. It constitutes a prevalent and serious complication of pregnancy, posing a significant threat to the health of both the pregnant woman and the fetus. This review aims to provide a comprehensive and detailed summary of knowledge by exploring the etiology, diagnostic methods, potential complications, and management strategies associated with pregnancy-induced hypertension. A profound understanding of these aspects will facilitate healthcare professionals, physicians, and researchers in better comprehending and addressing the disease, enabling timely diagnosis, prevention, and treatment measures to mitigate adverse outcomes. Furthermore, this review underscores the importance of pregnancy-induced hypertension, promoting awareness and attention to the condition, and offering relevant education and health guidance to the public to safeguard the health and well-being of pregnant women and their fetuses.

KEYWORDS

Pregnancy; hypertension; diagnosis; treatment strategies

CITE THIS PAPER

Caixia Liu, Xiaoli Liu, Hypertensive Disorders of Pregnancy: Causes, Diagnosis, Complications, and Management Strategies. MEDS Clinical Medicine (2024) Vol. 5: 61-70. DOI: http://dx.doi.org/10.23977/medsc.2024.050111.

REFERENCES

[1] Lewandowska, Małgorzata. "The association of familial hypertension and risk of gestational hypertension and preeclampsia." International Journal of Environmental Research and Public Health 18.13 (2021): 7045.
[2] Wu, Chia-Tung, et al. "Association of family history with incidence and gestational hypertension outcomes of preeclampsia." International Journal of Cardiology Hypertension 9 (2021): 100084.
[3] Honigberg, Michael C., et al. "Polygenic prediction of preeclampsia and gestational hypertension." Nature Medicine (2023): 1-10.
[4] Zhou, Shu, Yiping Ji, and Haimei Wang. "The risk factors of gestational hypertension in patients with polycystic ovary syndrome: a retrospective analysis." BMC Pregnancy and Childbirth 21.1 (2021): 336.
[5] Ongun, Mert C., et al. "Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension." Placenta 137 (2023): 88-95.
[6] Kuciene, Renata, and Virginija Dulskiene. "Associations of maternal gestational hypertension with high blood pressure and overweight/obesity in their adolescent offspring: a retrospective cohort study." Scientific Reports 12.1 (2022): 3800.
[7] Gaillard R, Steegers E A P, Hofman A, et al. Associations of maternal obesity with blood pressure and the risks of gestational hypertensive disorders. The Generation R Study[J]. Journal of hypertension, 2011, 29(5): 937-944.
[8] Zhou, Cheng, et al. "Early prediction model of gestational hypertension by multi-biomarkers before 20 weeks gestation." Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy (2021): 2441-2451.
[9] Li, Qian, et al. "Folic acid supplement use and increased risk of gestational hypertension." Hypertension 76.1 (2020): 150-156.
[10] Bilbeisi, El, et al. "Assessment of serum, dietary zinc levels, and other risk factors during the third trimester among pregnant women with and without pregnancy-induced hypertension: a case-control study." Frontiers in Nutrition 10 (2023): 1155529.
[11] Kumar, C. H., et al. "Pregnancy-induced hypertension: risk factors and current treatment strategies." Cellular, Molecular and Biomedical Reports 3.4 (2023): 197-204.
[12] De Giuseppe, Rachele, et al. "Mediterranean diet and lifestyle habits during pregnancy: is there an association with small for gestational age infants? An Italian single centre experience." Nutrients 13.6 (2021): 1941.
[13] Wiertsema, Clarissa J., et al. "Associations of DASH diet in pregnancy with blood pressure patterns, placental hemodynamics, and gestational hypertensive disorders." Journal of the American Heart Association 10.1 (2021): e017503.
[14] De Ocampo, Maria PG, et al. "Folic acid supplement use and the risk of gestational hypertension and preeclampsia." Women and Birth 31.2 (2018): e77-e83.
[15] Li, Qian, et al. "Folic acid supplement use and increased risk of gestational hypertension." Hypertension 76.1 (2020): 150-156.
[16] Li, Zhiwen, et al. "Folic acid supplementation during early pregnancy and the risk of gestational hypertension and preeclampsia." Hypertension 61.4 (2013): 873-879.
[17] Lu-Culligan, Alice, et al. "Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface." Med 2.5 (2021): 591-610.
[18] Fengmei S H I, Aijun Y U, Limei Y. Clinical significance of detection of coagulation indexes, immune factors and inflammatory factors in patients with pregnancy-induced hypertension syndrome in China[J]. Iranian Journal of Public Health, 2019, 48(4): 681.
[19] Couceiro J, Matos I, Mendes J J, et al. Inflammatory factors, genetic variants, and predisposition for preterm birth[J]. Clinical Genetics, 2021, 100(4): 357-367.
[20] van Rijn B B, Bruinse H W, Veerbeek J H, et al. Postpartum circulating markers of inflammation and the systemic acute-phase response after early-onset preeclampsia[J]. Hypertension, 2016, 67(2): 404-414.
[21] Allotey, John, et al. "Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis." bmj 370 (2020).
[22] Beyuo, Titus K., et al. "Clinical presentation and predictors of eclampsia among women with hypertensive disorders of pregnancy in Ghana." Pregnancy Hypertension 30 (2022): 171-176.
[23] Hauspurg, Alisse, and Arun Jeyabalan. "Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy." American Journal of Obstetrics and Gynecology 226.2 (2022): S1211-S1221.
[24] Toloza, Freddy JK, et al. "Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis." The Lancet Diabetes & Endocrinology (2022).
[25] Lau, Katherine GY, et al. "Ophthalmic artery peak systolic velocity ratio distinguishes pre‐eclampsia from chronic and gestational hypertension: A prospective cohort study." BJOG: An International Journal of Obstetrics & Gynaecology 129.8 (2022): 1386-1393.
[26] Yan, Shiyu, et al. "Association of gestational hypertension and preeclampsia with offspring adiposity: A systematic review and meta-analysis." Frontiers in Endocrinology 13 (2022): 906781.
[27] Magee L A, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy [J]. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 2014, 4(2): 105-145.
[28] Magee L A, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary[J]. Journal of Obstetrics and Gynaecology Canada, 2014, 36(5): 416-438.
[29] Tranquilli A L, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP[J]. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 2014, 4(2): 97-104.
[30] Sutton A L M, Harper L M, Tita A T N. Hypertensive disorders in pregnancy[J]. Obstetrics and Gynecology Clinics, 2018, 45(2): 333-347.
[31] Woo Kinshella M L, Sarr C, Sandhu A, et al. Calcium for pre‐eclampsia prevention: a systematic review and network meta‐analysis to guide personalised antenatal care[J]. BJOG: An International Journal of Obstetrics & Gynaecology, 2022, 129(11): 1833-1843.
[32] Hsu, Chien-Ning, et al. "Dietary Supplementation with Cysteine during Pregnancy Rescues Maternal Chronic Kidney Disease-Induced Hypertension in Male Rat Offspring: The Impact of Hydrogen Sulfide and Microbiota-Derived Tryptophan Metabolites." Antioxidants 11.3 (2022): 483.
[33] Wu, Jingjing, et al. "Paeoniflorin alleviates NG-nitro-L-arginine methyl ester (L-NAME)-induced gestational hypertension and upregulates silent information regulator 2 related enzyme 1 (SIRT1) to reduce H2O2-induced endothelial cell damage." Bioengineered 13.2 (2022): 2248-2258.
[34] Shen, Qi, et al. "Sensitive detection of single-nucleotide polymorphisms by conjugated polymers for personalized treatment of hypertension." Science Translational Medicine 15.686 (2023): eabq5753.
[35] Imai, Yutaka. "A personal history of research on hypertension From an encounter with hypertension to the development of hypertension practice based on out-of-clinic blood pressure measurements." Hypertension Research 45.11 (2022): 1726-1742.
[36] Graf, William D., et al. "Fetal anomaly diagnosis and termination of pregnancy." Developmental Medicine & Child Neurology (2023).
[37] Dahma, George, et al. "A Prospective Analysis of Vitamin D Levels in Pregnant Women Diagnosed with Gestational Hypertension after SARS-CoV-2 Infection." Journal of Personalized Medicine 13.2 (2023): 317.
[38] Penning, Louis C., et al. "A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment." Biomedicines 11.2 (2023): 420.

Downloads: 4543
Visits: 196542

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.